NCT06373744Completed
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Source: ClinicalTrials.gov · Last updated 18 Apr 2024
Brief summary (registry, in English)
The goal of this observational study is to learn about the effects of metronomic chemotherapy in advanced breast cancer patients. The main question it aims to answer is: How effective is metronomic chemotherapy in advanced breast cancer? Specific benefit groups of metronomic chemotherapy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 597 (actual)
- First submitted
- 16 Apr 2024
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- Sun Yat-sen University
- Diseases
- Metastatic breast cancer
- NCT number
- NCT06373744
What you commit to
- Study type: Observational
- Participants enrolled: 597
- From 1 Jan 2023 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking the drug for less than 2 weeks;
- losing follow-up after taking the therapy;
Other illness
- The patient's breast cancer was still in the early stage when taking the therapy.
Who the study is looking for
- Females, \>18 years old;
- Diagnosed with advanced breast cancer when using metronomic chemotherapy;
- At least one clinical evaluation, including physical examination and imaging, according to the instructions of the supervising physician during the use of metronomic chemotherapy. Examinations include ultrasound, computed tomography, and magnetic resonance imaging;
- Metronomic chemotherapy can be used alone, and patients who use it in combination with other drugs can also be included;
- The clinical pathological information that needs to be collected is complete.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shusen Wang Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.